Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06766760

Surgical Treatment for Patients With Obstructive Sleep Apnea by Using Da Vinci SP Surgical System

This prospective, interventional, non-randomized, single arm, clinical trial will investigate feasibility and safety of trans-oral robotic surgery using da Vinci SP Surgical System in Taiwan for the surgical treatment of OSA. All the investigators are well trained and have received proof of training after completing the training program for da Vinci SP system provided by Intuitive.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Linkou Chang Gung Memorial Hospital

Taoyuan, Taiwan

About this study

This study will be conducted in Chang Gung Memorial Hospital at Linkou.

Informed consent will be provided to patient who has an indication of surgical treatment for OSA. Study participants will sign an informed consent before any study procedure begins. Eligibilities will be assessed during screening period (2 weeks) with blood test and other routine assessments. Eligible patient will undergo surgical intervention using da Vinci SP Surgical System. Post-operation follow-up will be performed at 1 week, 1 month, 3 months, and 6 months.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 years or more.
  • OSA with AHI ≥ 15
  • Has failed, refuses, or is unable to tolerate CPAP therapy
  • Indication of resection of tongue base with/without other invasive surgical procedure for OSA (i.e. tongue base resection only or multi-level surgery with tongue base resection)
  • ASA physical status classification 1-2 and adequate organ function
  • Patients willing and able to comply with study protocol requirements and follow-up
  • Informed consent

Exclusion criteria

  • BMI>35
  • Mouth opening too narrow for TORS or trismus
  • Betel nut chewing
  • Suspicious cancer diagnosis
  • Prior head-and-neck surgery (note: prior invasive therapy for OSA allowed)
  • Other medical condition or anatomical factor not suitable for TORS, including subject with congenital malformations in the larynx, throat or tongue; 1. Subject with an American Society of Anesthesiologists (ASA) score of Grade 4 or above during preoperative evaluation
  • Active infectious disease
  • Can't follow trial-required procedures
  • Severe concomitant illness that drastically shortens life expectancy or increases risk of therapeutic interventions
  • Severe heart disease (NYHA functional class III-IV)
  • Severe lung disease (GOLD Group C-D)
  • Long-term use of anti-coagulant
  • Patients with coagulopathy
  • Emergency surgery
  • Subject for whom any additional surgeries are planned for OSA within the study period, after the surgery in which the da Vinci SP System was used
  • Subject is pregnant or suspected to be pregnant

Treatment and study plan

Da Vinci SP Surgical System, Model SP1098

Device

The da Vinci SP Surgical System is intended to assist in the accurate control of the da Vinci SP endoscope and instruments during minimally invasive endoscopic abdominopelvic, thoracoscopic, transoral otolaryngology, and breast surgical procedures. The system is indicated for adult use. It is intended to be used by trained physicians in an operating room environment.

Primary outcomes

  1. Conversion rate

    Time frame: 3 months (+60 days) post-surgery

    Success of tongue base resection without conversion to alternative surgery

  2. Apena Hypopnea Index

    Time frame: 3 months (+60 days) post-surgery

    Type I PSG measurements demonstrating Apena Hypopnea Index (AHI) reduction. An AHI of < 20 events/hour and a reduction in AHI of 50% or greater from baseline levels will be defined as success, when evaluated at 3 months (+60 days) post-surgery. Although it does not meet these criteria, it can be interpreted as an "improved" result when AHI is improved after surgery.

Secondary outcomes

  1. Multi-level surgery

    Time frame: Intraoperative

    Multi-level surgery (procedure used)

  2. Snoring Scale

    Time frame: 3 months (+60 days) post-surgery

    Snoring VAS

  3. Operative time

    Time frame: Intraoperative

    Operative time (first skin incision to closure of wound)

  4. Console time

    Time frame: 3 months (+60 days) post-surgery

    Console time

  5. Transfusion and estimated blood loss

    Time frame: 3 months (+60 days) post-surgery

    Transfusion and estimated blood loss

  6. Length of hospital stay

    Time frame: 3 months (+60 days) post-surgery

    Length of hospital stay

  7. Complication rate

    Time frame: 30 days

    Rate, intraoperative and/or postoperative, Clavien system

  8. Readmission rate

    Time frame: 30 days

    Readmission rate

  9. Reoperation rate

    Time frame: 30 days

    Reoperation rate

  10. Perioperative mortality

    Time frame: 30 days

    Perioperative mortality

  11. Volume of resected tissue

    Time frame: 3 months (+60 days) post-surgery

    measured using the volume displacement method

  12. Pain score

    Time frame: 3 months (+60 days) post-surgery

    Pain score (VAS)

  13. Sleepiness Scale

    Time frame: 3 months (+60 days) post-surgery

    Epworth Sleepiness Scale (ESS) and Stanford Sleepiness Scale (SSS) at 3 months (+60 days) post-surgery compared to baseline

  14. Pittsburgh Sleep Quality Index (PSQI)

    Time frame: at 1, 3, 6 months post-surgery

    Pittsburgh Sleep Quality Index (PSQI) at 1, 3, 6 months post-surgery compared to baseline.

  15. Adverse Events

    Time frame: within 3 months (+60 days) post-surgery

    Assessment of all reported adverse events (AE) within 3 months, (+60 days) post-surgery. Summarizing the incidence and frequency of all reported adverse events and categorizing them using CTCAE.

Other outcomes

  1. Imaging analysis

    Time frame: 3 months (+60 days) post-surgery

    Imaging analysis for resected tissue volume

  2. Percentages of sleep stages

    Time frame: 3 months (+60 days) post-surgery

    Percentages of sleep stages (N1, N2, N3, R), at 3 months (+60 days) post-surgery compared to baseline.

  3. Lowest oxygen saturation (LSAT)

    Time frame: 3 months (+60 days) post-surgery

    Lowest oxygen saturation (LSAT), at 3 months (+60 days) post-surgery compared to baseline.

  4. Percentages of sleep time

    Time frame: 3 months (+60 days) post-surgery

    Percent sleep time below 90% oxygen saturation (ST90) at 3 months (+60 days) post-surgery compared to baseline.

Study contacts

Contact information is provided by the study sponsor or research team.

Tuan-Jen Fang

CONTACT

[email protected]

+886-3-32801200 ext. 3971

Sponsors and collaborators

Lead sponsor

Chang Gung Memorial Hospital

Other

Registry information

Official study title

A Pilot Study of Single-port Robot-assisted Surgery Using da Vinci SP Surgical System for the Surgical Treatment for Patients With Obstructive Sleep Apnea

Important dates

Study start
2025
Primary completion
2025
Study completion
2026
First posted
Jan 9, 2025
Registry last updated
Jan 9, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.